Do patients with demyelinating disease have antibodies against human glial cells in their sera?
Open Access
- 1 February 1981
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 44 (2) , 164-167
- https://doi.org/10.1136/jnnp.44.2.164
Abstract
Cell-type-specific markers and indirect immunofluorescence were used to study immunoglobulin binding to glial cells in dissociated cell cultures of human foetal optic nerve, spinal cord and dorsal root ganglion in sera from patients with demyelinating diseases, other neurological diseases and normal controls. These various sera proved to be indistinguishable in that almost all of them contained immunoglobulin which bound weakly to all oligodendrocytes and fibroblasts, 5-25% of astrocytes and about 50% of Schwann cells.This publication has 10 references indexed in Scilit:
- CELL TYPE-SPECIFIC MARKERS FOR HUMAN GLIAL AND NEURONAL CELLS IN CULTURE1980
- A search for antibodies against glial cells in the serum and cerebrospinal fluid of patients with multiple sclerosis and Guillain-Barré syndromeJournal of the Neurological Sciences, 1979
- Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in cultureBrain Research, 1979
- Oligodendrocyte staining by multiple sclerosis serum is nonspecificAnnals of Neurology, 1979
- Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in cultureNature, 1978
- Antibodies to Oligodendroglia in Patients with Multiple SclerosisNew England Journal of Medicine, 1977
- DIAGNOSIS AND CLASSIFICATION OF MULTIPLE SCLEROSISBritish Medical Bulletin, 1977
- THE LIPID COMPOSITION OF PURIFIED BOVINE BRAIN MYELIN*Journal of Neurochemistry, 1966